Literature DB >> 18610471

Present treatment options in congestive heart failure.

W Remme.   

Abstract

Entities:  

Year:  1998        PMID: 18610471      PMCID: PMC1766488          DOI: 10.1136/hrt.79.2008.24s

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  15 in total

1.  Neuroendocrine response in acute heart failure and the influence of treatment.

Authors:  M Broqvist; U Dahlström; B E Karlberg; E Karlsson; T Marklund
Journal:  Eur Heart J       Date:  1989-12       Impact factor: 29.983

2.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

Review 3.  Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.

Authors:  V Dilsizian; R O Bonow
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

4.  Cardiovascular toxicity associated with yew leaf ingestion.

Authors:  J von der Werth; J J Murphy
Journal:  Br Heart J       Date:  1994-07

Review 5.  The role of neurohormonal activation in chronic heart failure and postmyocardial infarction.

Authors:  A Sigurdsson; K Swedberg
Journal:  Am Heart J       Date:  1996-07       Impact factor: 4.749

6.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

Authors:  S Yusuf; C J Pepine; C Garces; H Pouleur; D Salem; J Kostis; C Benedict; M Rousseau; M Bourassa; B Pitt
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

7.  Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.

Authors:  J Nussberger; E Fleck; H Bahrmann; W Delius; H P Schultheiss; H R Brunner
Journal:  Eur Heart J       Date:  1994-12       Impact factor: 29.983

8.  Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.

Authors:  J D Rutherford; M A Pfeffer; L A Moyé; B R Davis; G C Flaker; P R Kowey; G A Lamas; H S Miller; M Packer; J L Rouleau
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

Review 9.  Mechanisms of angiotensin II formation in humans.

Authors:  H Urata; H Nishimura; D Ganten
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

Review 10.  Neurohormonal modulation in heart failure: ACE inhibition and beyond.

Authors:  W J Remme
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

View more
  1 in total

Review 1.  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

Authors:  D J van Kraaij; R W Jansen; F W Gribnau; W H Hoefnagels
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.